The present invention provides a method for identifying a peptide which binds to an anti-double stranded DNA antibody. The present invention also provides a class of peptides identified by the method of the present invention which bind to anti-double stranded DNA antibodies and compositions containing these peptides. The present invention also provides methods for the diagnosis and treatment of systemic lupus erythematosus utilizing the peptides of the present invention.
Peptides For Detecting Anti-Double Stranded Dna Antibody And Uses Thereof
Bruce D. Gaynor - Pelham NY, US Betty A. Diamond - Bronx NY, US Matthew D. Scharff - Larchmont NY, US Philippe Valadon - New York NY, US
Assignee:
Albert Einstein College of Medicine of Yeshiva University - Bronx NY
International Classification:
G01N 33/53
US Classification:
435 71
Abstract:
The present invention provides a method for identifying a peptide which binds to an anti-double stranded DNA antibody. The present invention also provides a class of peptides identified by the method of the present invention which bind to anti-double stranded DNA antibodies and compositions containing these peptides. The present invention also provides methods for the diagnosis and treatment of systemic lupus erythematosus utilizing the peptides of the present invention.
Peptides Which Bind To Anti-Double Stranded Dna Antibody
Bruce D. Gaynor - Pelham NY Betty A. Diamond - Bronx NY Matthew D. Scharff - Larchmont NY Philippe Valadon - New York NY
Assignee:
Albert Einstein College of Medicine of Yeshiva University - Bronx NY
International Classification:
C07K 706 C07K 708
US Classification:
530330
Abstract:
The present invention provides a method for identifying a peptide which binds to an anti-double stranded DNA antibody. The present invention also provides a class of peptides identified by the method of the present invention which bind to anti-double stranded DNA antibodies and compositions containing these peptides. The present invention also provides methods for the diagnosis and treatment of systemic lupus erythematosus utilizing the peptides of the present invention.
BRUCE D. GAYNOR, M.D., MEDICAL CORPORATION 4720 Hoen Ave, Santa Rosa, CA 95405 (707)5278222 (Phone), (707)5275318 (Fax)
Certifications:
Internal Medicine, 1992 Ophthalmology, 2013
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
BRUCE D. GAYNOR, M.D., MEDICAL CORPORATION 4720 Hoen Ave, Santa Rosa, CA 95405
Santa Rosa Memorial Hospital 1165 Montgomery Drive, Santa Rosa, CA 95405
Education:
Medical School Rosalind Franklin University of Medicine and Science / Chicago Medical School Graduated: 1989 Medical School Albert Einstein Coll Med Graduated: 1989 Medical School Lenox Hill Hosp/Nyu Graduated: 1989 Medical School University Of California-San Francisco Graduated: 1989